Hazard
87 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 87 prescription drug recalls we have scored against our rubric, 1 (1%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all prescription drug recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Lidocaine HCl Injection USP in 5 mL single-dose ampules distributed by Spectra Medical Devices is being recalled for lack of assurance of sterility. 210,625 ampules affected.
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, are being recalled after failing dissolution specifications, with olmesartan medoxomil content below specification.
Lannett Niacin Extended-release Tablets, 1,000 mg, are being recalled after a stability test returned an out-of-specification low result for Stage 3 dissolution at 24 hours.
Duloxetine DR Capsules, 30 mg, relabeled by Enovachem are being recalled over CGMP deviations and N-nitroso-duloxetine above the FDA acceptable intake limit.
Xyvona levorphanol tartrate tablets, 2 mg, are being recalled following FDA's denial of marketing the product under the proprietary name Xyvona.
Eugia Lidocaine HCl Injection, USP 2% single-dose vials are being recalled because the label wrap covers the barcode, making it hard to scan. 168,300 vials are affected.
Xyvona levorphanol tartrate tablets, 3 mg, are being recalled following FDA's denial of marketing the product under the proprietary name Xyvona.
Pred Mild prednisolone acetate ophthalmic suspension 0.12% is being recalled after failing stability specifications. 2,736 bottles are affected.
Lidocaine HCl Injection, USP 2% in 5 mL single-dose vials manufactured by Huons is being recalled for lack of assurance of sterility. All lots within expiry are affected.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 60 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 96,096 bottles are affected.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 90 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 63,192 bottles are affected.
Lidocaine HCl Injection, USP 1% in 5 mL single dose vials manufactured by Huons is being recalled for lack of assurance of sterility. All lots within expiry are affected.
Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP ampules are being recalled for lack of assurance of sterility. The action covers 3,260,170 ampules.
0.9% Sodium Chloride Injection, USP in 10 mL single dose ampules supplied for Spectra Medical Devices is being recalled for lack of assurance of sterility. 7,120,750 ampules are affected.
International Medication Systems is recalling one lot of Epinephrine Injection, USP, 1 mg/10 mL, citing lack of assurance of sterility. 81,520 units are affected.
Major Pharmaceuticals is recalling one lot of Memantine Hydrochloride Extended-Release Capsules, 7 mg, after the product failed dissolution specifications.
Cipla is recalling Cinacalcet Hydrochloride Tablets, 30 mg, over CGMP deviations and the presence of N-Nitroso Cinacalcet above the acceptable daily intake limit. 113,336 bottles are affected.
Apotek is recalling one lot of Desmopressin Nasal Spray, USP because of a defect in a batch of bottle caps involving dislodged or missing cap liners.
Taro is recalling one lot of Fluocinonide 0.05% Cream in 30 g tubes after stability testing returned viscosity results above the specification limit. 41,712 tubes are affected.
Taro is recalling one lot of Fluocinonide 0.05% Cream in 60 g tubes after stability testing returned viscosity results above the specification limit. 2,640 tubes are affected.
Nephron is recalling one lot of Albuterol Sulfate Inhalation Solution 0.5% unit-dose vials because of an illegible label. The action covers 146,280 vials.
Taro is recalling one lot of Fluocinonide 0.05% Cream after stability testing returned out-of-specification viscosity results above the specification limit. 24,672 tubes are affected.
Cipla is recalling Lanreotide Injection 120 mg/0.5 mL prefilled syringes for lack of assurance of sterility, following an FDA observation of deficiencies in visual inspection at the contract manufacturing site.
Teva is recalling three lots of Isotretinoin Capsules, USP, 30 mg because the product was found to be superpotent and subpotent. 21,984 packages are affected.
Fresenius Kabi is recalling 5% Dextrose Injection, USP, 2.5 g per 50 mL supplied in 100 mL freeflex bags, citing lack of assurance of sterility.